Bridgewater, NJ, United States of America

Ashok Arasappan

This inventor holds 49 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 19 EPO patents, primarily in Hepatitis C Inhibitors. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Dendreon Corporation. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashok Arasappan. Retrieved from https://idiyas.com/inventor/ashok-arasappan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 49 (Patent Applications = 10)

% Patents Active = 69.4

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 19 (Patent Applications = 25)

Average Co-Inventor Count = 9.6

ph-index = 16

Forward Citations = 782(Granted Patents)

Company Filing History:

Merck Sharp + Dohme Corp.

Southern Research Institute

patents

5. 2 out of 67

Merck Sharp & Dohme LLC

Merck Shapr & Dohme Corp.

patent

8. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Hepatitis C Virus

NS3 Serine Protease

mGluR2 Modulators

Nucleoside Derivatives

PDE9 Inhibitors

Pyrazolopyrimidine

Oxazolidine

Diabetic Agents

Viral Infections

Tetrahydronaphthyridine

Benzimidazole

Cyclobutyl Compounds

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723035 - Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as Nav1.8 inhibitors (2026-09-01),

2. 12516046 - 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors (2026-01-06),

3. 12247031 - Cyclobutyl pyrazolopyrimidine PDE9 inhibitors (2025-03-11),

4. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors (2025-01-14),

5. 11802122 - 2-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors (2023-10-31),

6. 11377438 - 2-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors (2022-07-05),

7. 11028092 - Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors (2021-06-08),

8. 10934294 - Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors (2021-03-02),

9. 10806724 - Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2020-10-20),

10. 10335399 - Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2—negative allosteric modulators, compositions, and their use (2019-07-02),

11. 10072003 - Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2018-09-11),

12. 9868733 - Azabenzimidazole tetrahydrofuran derivatives (2018-01-16),

13. 9650375 - Indole derivatives useful as anti-diabetic agents (2017-05-16),

14. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives (2017-01-31),

15. 9433621 - Substituted pyridine and pyrimidine derivatives and their use in treating viral infections (2016-09-06),

Title: The Innovative Journey of Ashok Arasappan

Introduction: Ashok Arasappan, a talented inventor based in Bridgewater, NJ (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Ashok Arasappan holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, Ashok Arasappan has worked tirelessly to push the boundaries of innovation. His dedication to research and development has led to the creation of cutting-edge technologies that have revolutionized industries.

Collaborations: Throughout his career, Ashok Arasappan has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Ashok Arasappan's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions have not only transformed industries but have also inspired the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.